Duopa

Product manufactured by Abbvie Inc.

Application Nr Approved Date Route Status External Links
NDA203952 None Enteral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Duopa ® Is Indicated For The Treatment Of Motor Fluctuations In Patients With Advanced Parkinson’s Disease. Duopa Is A Combination Of Carbidopa (an Aromatic Amino Acid Decarboxylation Inhibitor) And Levodopa (an Aromatic Amino Acid) Indicated For The Treatment Of Motor Fluctuations In Patients With Advanced Parkinson’s Disease (1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Name Structure ZINC ID(s)
1. Carbidopa CARBIDOPA ZINC19168887
2. Levodopa LEVODOPA ZINC895199

Comments